168770-44-3

Basic information

• Product Name: 5-FLUORO-3-NITRO-2-METHYLANILINE
• Synonyms: 5-FLUORO-3-NITRO-2-METHYLANILINE;5-FLURO-3-NITRO-2-METHYLANILINE;5-Fluoro-2-Methyl-3-nitroaniline;2-amino-4-fluoro-6-nitro-toluene
• CAS NO: 168770-44-3
• Molecular Formula: C₇H₇FN₂O₂
• Molecular Weight: 170.1410832
• EINECS: 200-258-5
• Mol File: 168770-44-3.mol

Chemical Properties

• Boiling Point: 311.5±37.0 °C(Predicted)
• Appearance: /
• Density: 1.371±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 1.09±0.10(Predicted)
• CAS DataBase Reference: 5-FLUORO-3-NITRO-2-METHYLANILINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-FLUORO-3-NITRO-2-METHYLANILINE(168770-44-3)
• EPA Substance Registry System: 5-FLUORO-3-NITRO-2-METHYLANILINE(168770-44-3)

Safety Data

• Hazardous Substances Data: 168770-44-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5-FLUORO-3-NITRO-2-METHYLANILINE is used as an intermediate in the synthesis of various pharmaceutical compounds for its reactivity and structural properties that can be leveraged to create new drugs with specific therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, 5-FLUORO-3-NITRO-2-METHYLANILINE is utilized as a precursor in the development of agrochemicals, potentially contributing to the creation of new pesticides or herbicides that can enhance crop protection and yield.
Used in Dye Industry:
5-FLUORO-3-NITRO-2-METHYLANILINE is employed as a building block in the production of dyes, where its chemical structure can be manipulated to produce a range of colors and properties suitable for various applications, including textiles and other industrial uses.
Used in Research and Development:
5-FLUORO-3-NITRO-2-METHYLANILINE is used as a subject of research in medicinal chemistry, where its unique structure and reactivity are explored to understand its potential pharmacological properties and to develop new therapeutic agents.

Upstream product

• 446-10-6 2-nitro-4-fluorotoluene 
• 352-32-9 p-fluorotoluene 
• 102735-88-6 5-fluoro-2-methyl-1,3-dinitrobenzene 

Downstream Products

• 1167055-65-3 C₈H₈FNO₃ 
• 1058142-18-9 ethyl 6-fluoro-4[(phenoxycarbonyl)amino]-1H-indazole-1-carboxylate 
• 885520-14-9 6-fluoro-4-nitro-1H-indazole 

Relevant articles and documents

QUINAZOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATIONS

Disclosed are a quinazolinone derivative, a preparation method therefor, a pharmaceutical composition, and applications. Provided are a compound represented by formula I, a pharmaceutically acceptable salt, a solvate, a crystal form, a eutectic crystal, a

Indazole compounds and application thereof to preparation of IDO inhibitors

The invention discloses indazole compounds as shown in a formula (i) or (II) which is described in the specification, and a preparation method thereof, and application of the compounds as IDO inhibitors. The compounds provided by the invention can be used for preventing and/or treating a plurality of diseases, such as Alzheimer's disease, cataract, infections related to cellular immune activation,autoimmune diseases, AIDS, cancers, depression, the metabolic disorder of tryptophan or the like.

Indazole compounds containing nitrogen substituents, and application of same as IDO inhibitors

The invention discloses nitrogen substituent-containing indazole compounds as shown in a formula (I) which is described in the specification, a preparation method for the compounds, and application ofthe compounds as IDO inhibitors. The compounds provided by the invention can be used for preventing and/or treating a plurality of diseases, such as Alzheimer's disease, cataract, infections relatedto cellular immune activation, autoimmune diseases, AIDS, cancers, depression, the metabolic disorder of tryptophan or the like.

MINERALOCORTICOID RECEPTOR ANTAGONISTS

The present invention is directed to compounds of the Formula I: as well as pharmaceutically acceptable salts thereof, that may be useful for treating aldosterone-mediated diseases. The invention furthermore relates to specific diastereomers and enantiome

SUBSTITUTED AROMATIC CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted aromatic carboxamide and urea derivatives, to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions (formula (I)).

INDAZOLE DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS

The present invention relates to indazole derivatives of the following formula I, which can be used as vanilloid receptor ligands, processes for their preparation, and their use in treating diseases, conditions and/or disorders modulated by vanilloid receptors. (I)

7-(2-IMIDAZOLINYLAMINO)QUINOLINE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS

This invention involves involves the use of compounds having the following structure: STR1 wherein: (a) R is unsubstituted C 1-C. sub.3 alkanyl or alkenyl; and(b) R' is selected from hydrogen; unsubstituted C 1-C 3 alkanyl or alkenyl; unsubstituted

7-(2-IMIDAZOLINYLAMINO)QUINOLINE COMPOUNDS USEFUL AS ALPHA-2-ADRENOCEPTOR AGONISTS

The subject invention involves methods of treating nasal congestion comprising administration, to a human or lower animal in need of such treatment of a safe and effective amount of a compound having the following structure: STR1 wherein: (a) R is unsubst

7-(2-IMIDAZOLNYLAMINO) QUINOLINE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS

The subject invention involves methods of treating nasal congestion comprising administration, to a human or lower animal in need of such treatment of a safe and effective amount of a compound having the following structure: STR1 wherein: (a) R is unsubst